2-(3-Methylpyridin-2-yl)acetic acid | 1000565-37-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 2-(3-Methylpyridin-2-yl)acetic acid
• CAS: 1000565-37-6
• 化学式: C₈H₉NO₂
• mdl: MFCD09924938
• 分子量: 151.165
• InChiKey: ISNRBXCLHQZOMF-UHFFFAOYSA-N

物化性质

• 沸点：
  297.3±25.0 °C(Predicted)
• 密度：
  1.196±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  0.7
• 重原子数：
  11
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  50.2
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1,3-bis(N-benzyloxycarbonyl)-3′-dihyro-3′-deoxy-3′(R)-amino spectinomycin 、 2-(3-Methylpyridin-2-yl)acetic acid 在 O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate 、 N,N-二异丙基乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.17h， 生成
  参考文献：
  名称：

  Spectinamide抗结核剂的结构与活性关系：核糖体抑制和天然外流避免贡献的解剖。

  摘要：

  Spectinamides是一类新型的抗结核药，具有治疗耐药性结核感染的潜力。它们的抗结核活性来源于核糖体亲和力和克服结核分枝杆菌介导的内在外排的能力RV1258C外排泵。这项研究通过分析50种靶向Sp​​ectinamides探索了结构-活性关系。评价化合物的核糖体翻译抑制作用，Rv1258c外排泵缺陷型和野生型结核菌株中的MIC活性，以及​​在急性肺结核感染模型中的功效。这项研究的结果显示出狭窄的结构-活性关系，与紧密的核糖体结合口袋和克服天然外排的严格结构要求相一致。使用分子动力学模拟对核糖体抑制数据的合理化表明，卤代Spectinamides形成稳定的复合物，与长期观察到的抗生素作用一致。结核分枝杆菌。此处详述的构效关系强调了在抗结核药物设计中必须检查外排介导的耐药性，并证明可以通过合成修饰克服内在排泄。了解此类结构要求的能力产生了多种新的取代的Spectinamides，它们可能

  DOI：

  10.1021/acsinfecdis.6b00158

文献信息

• HETEROCYCLIC COMPOUND AND USE THEREOF
  申请人：Takeda Pharmaceutical Company Limited

  公开号：US20190300536A1

  公开（公告）日：2019-10-03

  The present invention provides a heterocyclic compound having an antagonistic action on an NMDA receptor containing the NR2B subunit, and expected to be useful as an agent for the prophylaxis or treatment of major depression, bipolar disorder, migraine, pain, behavioral and psychological symptoms of dementia and the like. The present invention relates to a compound represented by the formula (I): wherein each symbol is as described in the description, or a salt thereof.

  本发明提供一种具有对包含NR2B亚基的NMDA受体具有拮抗作用的杂环化合物，预计可作为预防或治疗重度抑郁症、双相情感障碍、偏头痛、疼痛、痴呆症的行为和心理症状等的药物。本发明涉及一种由以下式（I）表示的化合物：其中每个符号如描述中所述，或其盐。
• Pyridazine Compound and Use Thereof
  申请人：Manabe Akio

  公开号：US20090275589A1

  公开（公告）日：2009-11-05

  A pyridazine compound of the formula: has an excellent plant disease controlling effect.

  一种化学式为的吡啶嗪化合物具有优良的植物病害控制效果。
• ACTIVE OXYGEN SPECIES MEASURING DEVICE
  申请人：Yuasa, Makoto

  公开号：EP1600766A1

  公开（公告）日：2005-11-30

  A reactive oxygen species measuring device according to the present invention comprises a reactive oxygen species sensor provided with an electrode assembly capable of detecting the presence of reactive oxygen species or the like in terms of an electric current, a power source means for applying a measuring voltage to the reactive oxygen species sensor, and a reactive oxygen species concentration measuring means for measuring a concentration of the reactive oxygen species or the like from the current detected by the reactive oxygen species sensor. According to the present invention, a concentration of reactive oxygen species or the like such as in vivo or in vitro superoxide anion radical (O2-.) can be measured reliably, and the entire device can be formed in a smaller size and always mounted to a living body. In addition, the measured data can be transmitted to a remote place or location, and further, the health condition of a living body or the like determined in the remote place can be returned to a measuring place and informed, and thus, the health condition of the living body can be monitored by measuring and monitoring reactive oxygen species.

  根据本发明，一种活性氧测量装置包括一个活性氧传感器，其电极组件能够以电流形式检测活性氧或类似物的存在；一个电源装置，用于向活性氧传感器施加测量电压；以及一个活性氧浓度测量装置，用于根据活性氧传感器检测到的电流测量活性氧或类似物的浓度。根据本发明，可以可靠地测量体内或体外超氧阴离子自由基（O2-.）等活性氧或类似物的浓度，而且整个装置可以形成较小的尺寸，并始终安装在活体上。此外，还可将测量数据传输到远程地点或位置，并进一步将远程地点确定的活体或类似物的健康状况返回到测量地点并告知，因此可通过测量和监测活性氧来监测活体的健康状况。
• AROMATIC HETEROCYCLIC COMPOUND
  申请人：Mitsubishi Tanabe Pharma Corporation

  公开号：EP2862856A1

  公开（公告）日：2015-04-22

  The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.

  由通式表示的化合物：其中环 A 是苯，可被取代等；环 B 是苯，可被取代等；X 是单键等；Y 是烷基，可被取代等；Z 是 CR1 或氮原子；R1 是氢等；R2 是烷基，可被取代等或其药学上可接受的盐，可用作肥胖症、糖尿病等的预防/治疗剂。
• Aromatic heterocyclic compound
  申请人：MITSUBISHI TANABE PHARMA CORPORATION

  公开号：US10308636B2

  公开（公告）日：2019-06-04

  The compound represented by the general formula: wherein ring A is benzene which may be substituted and the like; ring B is benzene which may be substituted and the like; X is a single bond and the like; Y is alkyl which may be substituted and the like; Z is CR1 or nitrogen atom; R1 is hydrogen and the like; R2 is alkyl which may be substituted and the like or a pharmaceutically acceptable salt thereof is useful as a prevention/treatment agent of obesity, diabetes, and the like.

  由通式表示的化合物：其中环 A 是苯，可被取代等；环 B 是苯，可被取代等；X 是单键等；Y 是烷基，可被取代等；Z 是 CR1 或氮原子；R1 是氢等；R2 是烷基，可被取代等或其药学上可接受的盐，可用作肥胖症、糖尿病等的预防/治疗剂。